ANNOVIS BIO INC. COMMON STOCK
7.4000
12-November-24 13:51:51
15 minutes delayed
Stocks
-0.2500
-3.27%
Today's range
7.3200 - 7.8000
ISIN
N/A
Source
NYSE
-
12 Nov 2024 07:00:01 By Nasdaq GlobeNewswire
-
Annovis Bio Reports Third Quarter Financial Results and Provides Business Update
11 Nov 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist
07 Nov 2024 07:00:01 By Nasdaq GlobeNewswire
-
Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
22 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs
15 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
03 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
02 Oct 2024 07:30:00 By Nasdaq GlobeNewswire
-
30 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference
05 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update
15 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist
06 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio Secures U.S. Patent for Treatment of Acute Traumatic Brain Injury with Buntanetap
24 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
16 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team
09 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
27 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
26 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
25 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
18 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
-
Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients
11 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >